Tezepelumab for severe asthma with cough
Treatments studied
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study tests a medicine called tezepelumab (an injection) for people with severe asthma who also have a chronic cough. It may help reduce asthma attacks and improve cough symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 79 years old.
- You have severe asthma that needs high-dose inhaled steroids or other medicines, and your symptoms are not well controlled.
- You have a chronic cough related to asthma that you rate as at least 30 out of 100 on a cough scale.
- You have had a positive airway test (like a methacholine or bronchodilator response test).
- You have not used another biologic (injection) asthma medication in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if tezepelumab can help reduce severe asthma attacks in children ages 5 to 11. It compares the drug to a placebo (a dummy treatment) to see if it is safe and effective.
This trial tests a medication called tezepelumab to see if it can improve symptoms for people with chronic sinusitis and nasal polyps who also have severe asthma. It may help reduce inflammation and improve breathing and nasal symptoms.
This study tests a new investigational biologic medicine called QL2302, which is given as an injection, to see if it works as well as a similar approved medicine (Tezspire) for people with severe asthma. If you qualify, you would receive either QL2302 or Tezspire, and the study will track how well your asthma is controlled and your lung function over time.
This study tests a new medicine called tozorakimab for adults whose asthma is not well controlled despite using their usual inhalers. It aims to see if it can reduce asthma attacks and improve symptoms.
This study tests an investigational medicine called tilrekimig for people with severe asthma that isn't well controlled. It aims to reduce asthma attacks and improve breathing.
This study tests a drug called tezepelumab for people with severe asthma that is not well controlled with current treatments. It aims to see if adding this drug can reduce asthma attacks and improve symptoms.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.